leading to kidney injury and/or dysfunction Acute decompensated heart failure, acute coronary syndrome Chronic cardiorenal (type 2) Chronic abnormalities in heart function (CHF-CHD) leading to ...

GALWAY, Ireland, February 13, 2025--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive data ...

Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...

WhiteSwell is a patient-focused company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits.

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.

WhiteSwell today announced positive data from 21 patients treated in a trial evaluating its eLym system for fluid removal.

At a three-day event, hepatology experts focused on improving patient outcomes, particularly in ICU care, while exploring ...